Literature DB >> 20114028

Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9.

Cevayir Coban1, Yoshikatsu Igari, Masanori Yagi, Thornik Reimer, Shohei Koyama, Taiki Aoshi, Keiichi Ohata, Toshihiro Tsukui, Fumihiko Takeshita, Kazuo Sakurai, Takahisa Ikegami, Atsushi Nakagawa, Toshihiro Horii, Gabriel Nuñez, Ken J Ishii, Shizuo Akira.   

Abstract

Although whole-parasite vaccine strategies for malaria infection have regained attention, their immunological mechanisms of action remain unclear. We find that immunization of mice with a crude blood stage extract of the malaria parasite Plasmodium falciparum elicits parasite antigen-specific immune responses via Toll-like receptor (TLR) 9 and that the malarial heme-detoxification byproduct, hemozoin (HZ), but not malarial DNA, produces a potent adjuvant effect. Malarial and synthetic (s)HZ bound TLR9 directly to induce conformational changes in the receptor. The adjuvant effect of sHZ depended on its method of synthesis and particle size. Although natural HZ acts as a TLR9 ligand, the adjuvant effects of synthetic HZ are independent of TLR9 or the NLRP3-inflammasome but are dependent on MyD88. The adjuvant function of sHZ was further validated in a canine antiallergen vaccine model. Thus, HZ can influence adaptive immune responses to malaria infection and may have therapeutic value in vaccine adjuvant development. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20114028     DOI: 10.1016/j.chom.2009.12.003

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  55 in total

1.  Natural hemozoin stimulates syncytiotrophoblast to secrete chemokines and recruit peripheral blood mononuclear cells.

Authors:  N W Lucchi; D Sarr; S O Owino; S M Mwalimu; D S Peterson; J M Moore
Journal:  Placenta       Date:  2011-05-31       Impact factor: 3.481

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 3.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

Review 4.  The Toll Pathway in the Central Nervous System of Flies and Mammals.

Authors:  Anat Shmueli; Tali Shalit; Eitan Okun; Galit Shohat-Ophir
Journal:  Neuromolecular Med       Date:  2018-10-01       Impact factor: 3.843

5.  Toll-like receptor 9 modulates macrophage antifungal effector function during innate recognition of Candida albicans and Saccharomyces cerevisiae.

Authors:  Pia V Kasperkovitz; Nida S Khan; Jenny M Tam; Michael K Mansour; Peter J Davids; Jatin M Vyas
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

6.  Cutting edge: nitrogen bisphosphonate-induced inflammation is dependent upon mast cells and IL-1.

Authors:  John T Norton; Tomoko Hayashi; Brian Crain; John S Cho; Lloyd S Miller; Maripat Corr; Dennis A Carson
Journal:  J Immunol       Date:  2012-03-02       Impact factor: 5.422

Review 7.  NLR proteins and parasitic disease.

Authors:  Gwendolyn M Clay; Fayyaz S Sutterwala; Mary E Wilson
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

Review 8.  Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors.

Authors:  Surya Pandey; Taro Kawai; Shizuo Akira
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-10-09       Impact factor: 10.005

9.  TLR9 is actively recruited to Aspergillus fumigatus phagosomes and requires the N-terminal proteolytic cleavage domain for proper intracellular trafficking.

Authors:  Pia V Kasperkovitz; Michael L Cardenas; Jatin M Vyas
Journal:  J Immunol       Date:  2010-11-08       Impact factor: 5.422

10.  Toll-like receptor 7 mediates early innate immune responses to malaria.

Authors:  Alyssa Baccarella; Mary F Fontana; Eunice C Chen; Charles C Kim
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.